Table 4.
Morbidity, recurrence, and mortality rates of the three study groups n (%)
| Group I (n = 28) | Group II (n = 93) | Group III (n = 251) | P | |
| Medical complications1 | 0.163 | |||
| Cardiac | 1 (3.6) | 1 (1.1) | 3 (1.2) | |
| Respiratory | 2 (7.2) | 3 (3.2) | 6 (2.4) | |
| Other | 1 (3.6) | 2 (2.2) | 4 (1.6) | |
| Surgical complications | ||||
| Wound infection | 6 (21.4) | 6 (6.5) | 9 (3.5) | 0.001b |
| Biliary fistula | 1 (3.6) | 9 (9.7) | 2 (0.8) | 0.001b |
| Intra-abdominal abscess | - | 1 (1.1) | 2 (0.8) | 0.855 |
| Incisional hernia | 2 (7.2) | 2 (2.2) | 3 (1.2) | 0.087 |
| Gastrocutaneous fistula | 1 (3.6) | - | - | 0.002b |
| Recurrence | 3 (10.7) | 3 (3.2) | 8 (3.2) | 0.132 |
| Mortality | - | 1 (1.1) | 3 (1.2) | 0.844 |
b
Values indicate a significant difference.
1
Cardiac complications included heart failure and myocardial infarction; respiratory complications included atelectasis, pneumonia, adult respiratory distress syndrome, and pulmonary embolus; other complications included urinary tract infection and acute thromboembolic disease of the lower extremities.